首页> 外国专利> TREATMENT OF C1013G/CXCR4-ASSOCIATED WALDENSTROM'S MACROGLOBULINEMIA WITH ANTI-CXCR4 ANTIBODY

TREATMENT OF C1013G/CXCR4-ASSOCIATED WALDENSTROM'S MACROGLOBULINEMIA WITH ANTI-CXCR4 ANTIBODY

机译:抗CXCR4抗体治疗C1013G / CXCR4关联的华氏巨噬细胞。

摘要

PROBLEM TO BE SOLVED: To provide a method for treating a subject afflicted with C1013G/CXCR4-associated Waldenstrom's macroglobulinemia (WM).;SOLUTION: The method comprises administering to the subject a therapeutically effective amount of an antibody or an antigen-binding portion thereof that specifically binds to a C-X-C chemokine receptor type 4 (CXCR4) receptor expressed on the surface of a Waldenstrom's macroglobulinemia cell. The disclosure also provides a therapeutic regimen for treating a patient afflicted with C1013G/CXCR4-associated WM.;SELECTED DRAWING: None;COPYRIGHT: (C)2020,JPO&INPIT
机译:解决的问题:提供一种治疗受C1013G / CXCR4相关的沃尔登斯特伦巨球蛋白血症(WM)折磨的对象的方法;解决方案:该方法包括向该对象给药治疗有效量的抗体或其抗原结合部分特异性结合Waldenstrom巨球蛋白血症细胞表面表达的CXC趋化因子受体4型(CXCR4)受体。本公开还提供了用于治疗患有C1013G / CXCR4相关的WM的患者的治疗方案。选图:无;版权:(C)2020,JPO&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号